Next Article in Journal
Interventions and Outcomes for Neoadjuvant Treatment of T4 Colon Cancer: A Scoping Review
Previous Article in Journal
Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20–22 February 2020
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 28
Issue 3
10.3390/curroncol28030190
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada

by
Leila Cattelan
1,
Feras M. Ghazawi
2,
Michelle Le
1,
François Lagacé
1,
Elham Rahme
3,
Andrei Zubarev
1,
Denis Sasseville
1,
Ivan V. Litvinov
1,
Kevin A. Waschke
4 and
Elena Netchiporouk
1,*
1
Division of Dermatology, McGill University, Montreal, QC H4A 3J1, Canada
2
Division of Dermatology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
3
Division of Clinical Epidemiology, McGill University, Montreal, QC H4A 3J1, Canada
4
Division of Gastroenterology, McGill University, Montreal, QC H4A 3J1, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2021, 28(3), 2052-2064; https://doi.org/10.3390/curroncol28030190
Submission received: 8 April 2021 / Revised: 11 May 2021 / Accepted: 18 May 2021 / Published: 28 May 2021
(This article belongs to the Section Gastrointestinal Oncology)
Browse Figures
Versions Notes

Abstract

:
Gastric cancer is the 5th most common malignancy worldwide, representing ~5–10% of all new cancer cases. Although its incidence is declining, it is estimated that 1 in 98 Canadians will develop gastric cancer in their lifetime. The epidemiology and distribution of gastric cancer throughout Canada, however, remains poorly understood. A retrospective analysis of demographic data across Canada between 1992 and 2010 was performed using 2 population-based cancer registries. The incidence of gastric cancer was examined at the levels of provinces, cities, and postal codes. In addition, 43,955 patients were diagnosed with gastric cancer in Canada between 1992 and 2010; 66% were male and the average age of diagnosis was 68.4 years. The age-adjusted incidence rate was 5.07 cases per 100,000 individuals per year. The incidence decreased over the study period by 30%. High incidence rates were identified in rural areas of Newfoundland and Labrador, New Brunswick, and Quebec. Our study found a significant association between gastric cancer incidence rates and lower socioeconomic status, as well as Hispanic ethnicity. This is the first study to provide a comprehensive analysis of the incidence of gastric carcinoma in Canada, identifying high-risk populations that may benefit from increased primary and secondary prevention.

1. Introduction

It is estimated that 1 in ~98 Canadians will develop gastric cancer, usually adenocarcinoma, in their lifetime [1,2]. It is more common in older men [3]. Gastric cancer is the 5th most common and the 3rd most deadly malignancy worldwide and is associated with socioeconomic injustice [3,4]. Its incidence varies greatly worldwide with the highest age-standardized incidence rates (ASIR) in Asia and South America [3]. Furthermore, a strong racial disparity is seen with ASIR of 10.7 per 100,000 individuals-year in Caucasian men vs. 20.8 per 100,000 in men of Asian/Pacific origin in the US [5]. Low socioeconomic status (SES), tobacco smoking, obesity, a diet high in meat, salty and processed foods, and finally, H. pylori infection are strongly associated with gastric cancer development and mortality [2,3,5,6,7,8,9,10,11,12]. In particular, SES may be a predictive risk factor of gastric cancer incidence due to the underlying occupational and lifestyle exposures. A recent study of Surveillance Epidemiology and End Results (SEER) data between 2000 to 2014 in the United States found that gastric cancer incidence was ~30% higher in lowest SES neighborhoods, when contrasted with highest SES neighborhoods [13]. A study conducted in Italy in 2011 demonstrated that in nearly all regions, over 25% of deaths secondary to gastric cancer could have been avoided if the population with a low to medium education level had a mortality rate that matched that of the population with a higher education level [14].
In support of the global effort to study health disparities due to racial and socioeconomic factors [15,16], we focused on identifying the geographic distribution of gastric cancer incidence across Canadian provinces and territories and correlated incidence rates with ethnicity, SES, and other health determinants.

2. Materials and Methods

This study was conducted in accordance with the CISS-RDC-668035 and 13-SSH-MCG-3749-S001 protocols approved by the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Quebec Inter-University Centre for Social Statistics (QICSS). An exemption from the McGill University Research Ethics Board review was obtained, in accordance with the institutional policy.

2.1. Data Extraction

Data were obtained from the Canadian Cancer Registry (CCR) and Le Régistre Québécois du Cancer (LRQC). International Classification of Disease (ICD) for Oncology ICD-O-3 codes were used for 10 subtypes of gastric adenocarcinoma (Table 1) similar to our prior studies [17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34]. Cases of gastric cancer were defined as the following: Adenocarcinoma (8140), intestinal adenocarcinoma (8144), diffuse adenocarcinoma (8145), tubular adenocarcinonma (8211), papillary adenocarcinoma (8260), mucinous adenocarcinoma (8480), signet ring cell carcinoma (8490), medullary carcinoma (8512), adenosquamous carcinoma (8560), and undifferentiated carcinoma (8020).
The CCR includes all cancer cases for 12 provinces and territories (excluding Quebec), diagnosed between 1992 to 2013. LRQC contains Quebec data for years 1992 to 2010. Since data from the LRQC database for Quebec were only available up to 2010, we chose to limit the analysis for this study between 1992 and 2010, for consistency. These databases provide demographic, geographic, and clinical information including sex, year, and age at diagnosis, province/city/forward sortation area (FSA). In Canada, postal codes consist of letters and numbers (e.g., H3G 1A4), where the first 3 entries (FSA) define a region in the country, with more than 1600 FSAs across Canada. Rural FSAs were defined as per the classification used by the Canada Post, in which a “0” as the second character of the FSA indicates a rural region, while a second character of “1” through “9” corresponded to an urban area.

2.2. Data Analysis

Incidence rates and 95% confidence intervals were calculated and reported overall, by year of diagnosis and specific geographic regions that were identified by the mapping analysis. CI were based on exact Poisson tests. Statistical significance was defined by 95% CI not overlapping with that of the national average 95% CI. The national age-standardized incidence rate for gastric cancer in Canada was calculated using the direct method with WHO 2000 to 2025 as the population standard. The age-standardized incidence rates by province, FSA, and per year were calculated using the indirect method. Incidence rates were plotted, and linear regression models were used to assess trends over time.

2.3. Mapping Analysis

Geographic maps of Canada, indicating the place of residence of patients recorded by the CCR, LRQC, and CVS databases, were generated using the geographic information systems software (Tableau 10.3 from Tableau Software, Seattle, WA, USA). Shape files used to create the geographic maps were obtained from Statistics Canada. Only FSAs with populations of at least 5000 individuals based on the census data were selected in order to reduce the risk of false-positive hits that could inflate the incidence rate.

2.4. SES/Ethnicity Analysis

Since CCR/LRQC databases do not record data concerning ethnicity nor SES, these data were retrieved from the 2001 and 2006 Canadian Census of Population. The median income was used to represent SES. Each FSA was placed into 1 of 5 quintiles based on the percentage of the population that is of Hispanic ethnicity (Q1 to Q5). Q1-Hispanic contains the FSAs with the least percentage of Hispanic individuals and Q5-Hispanic contains those with the highest percentage. Quintiles were compared with one another via incidence rate ratios (IRR) and their corresponding 95% confidence intervals. In addition to the quintile analyses, FSAs with significantly higher incidence rates than the national average were placed in one group, and those with significantly lower incidence rates in another. The average percentage of Hispanic individuals for each group was calculated and compared using the student T-test. The differences were considered significant when the p-value < 0.05. East Asian ethnicity and SES were analyzed using the same method. The conclusions derived from this analysis should be interpreted with caution, given that SES and ethnicity data by FSA were not directly available.

3. Results

The patients’ characteristics are presented in Table 2 total of 43,955 patients were diagnosed with gastric cancer between 1992 and 2010. The crude average national incidence rate (1992–2010) was 7.46 (95% CI: 7.39–7.53) cases per 100,000 individuals per year (Table 2) and average ASIR was 5.07 cases per 100,000 individuals per year (95% CI: 5.02–5.13). The majority of patients (66%) were males with ASIR of 6.74 (95% CI: 6.64–6.83) vs. ASIR of 3.41 (95% CI: 3.34–3.47) in females (1.95:1 male to female ratio). The average age of diagnosis was 68.4±0.5 years, with 75% of patients being ≥ 60 years. This incidence rate decreased significantly over the study period (Figure 1A) with 9.28 cases per 100,000 individual-year in 1992 and 6.59 cases per 100,000 individual-year in 2010 representing a ~30% decrease over 19 years or an annual percent change of 1.6%. The linear regression analysis incidence rate over time in [R2] was 0.9622; p = 0.002. The slope of the line is 0.148 cases per 100,000 individuals per year.
Analyses by area based-SES and ethnic composition demonstrated a significant association between gastric cancer incidence rates, SES, and Hispanic ethnicity (Table 3A,B). The incidence rates were significantly lower in the highest SES quintile compared to the lowest SES quintile (IRRSES Q5 vs. Q1 = 0.39; 95% CI 0.35–0.42 p < 0.001). In addition, the average median income in FSAs with statistically significant higher incidence rates was CAD 18, 700, whereas it was CAD 27,200 in FSAs with statistically significant lower gastric cancer rates (p < 0.001). For ethnicity, incidence rates were significantly higher in quintiles with a higher percentage of Hispanic individuals compared to quintiles with a lower percentage of Hispanic individuals (IRRHispanic Q5 vs. Q1 = 1.47, 95% CI 1.35–1.60 p < 0.001). In addition, the average percentage of Hispanic individuals in FSAs with statistically significant higher incidence rates was 1.34%, whereas it was 0.62% in FSAs with statistically significant lower cancer rates (p < 0.001). There was no significant association between gastric cancer incidence and East Asian ethnicity (IRREast AsiansQ5 vs. Q1 = 1.02, 95% CI 0.98–1.07) nor African Canadian/black ethnicity (IRRBlackQ5 vs. Q1 = 0.93–1.13).
The national ASIR was 5.07 cases per 100,000 individuals per year (95% CI: 5.02–5.13). Geographic maps illustrate age-standardized incidence rates of gastric cancer (per 100,000 individuals per year) relative to the national average based on the CCR/LRQC databases. On a provincial level, Newfoundland and Labrador, Nunavut, New Brunswick, Manitoba, Nova Scotia, and Quebec had significantly higher ASIR compared to the national average, with the highest being in Newfoundland and Labrador at 13.71 (95% CI, 12.99–13.76) cases per 100,000 individuals per year (Figure 1B). In contrast, British Columbia and Ontario had lower ASIR of 7.00 (95% CI = 6.82–7.01), and 6.86 (95% CI = 6.75–6.86) cases per 100,000 individuals, respectively. Alberta, Saskatchewan, and Prince Edward Island’s ASIRs were on par with the Canadian average (Figure 1B).
Canadian cities with a population over >5000 individuals with differential (high or low) crude incidence rates are presented in Table S1. Briefly, 61/634 cities had statistically higher incidence compared to the national average. Of these, 15 (25%) were in British Columbia, 14 (23%) in Quebec, 8 (13%) in New Brunswick, 6 (10%) in Newfoundland and Labrador, and 5 (8%) in Nova Scotia. When analyzed by FSA (Table S2 and Figure 2), a similar trend was observed with many high incidence FSAs being located in Quebec (39.8%, 70/174) and Newfoundland and Labrador (9.2%, 16/174).
Eleven FSAs had an ASIRs ≥ 3-fold that of the national average (Table S3). The majority of these FSAs (6/11) were located in Newfoundland and Labrador, while the remaining ones were in rural Quebec (3/11) and Nova Scotia (2/11). The highest ASIR corresponded to the FSA A0M, representing the La Poile Bay region of Newfoundland and Labrador, with the rate of 23.79 cases per 100,000 individuals per year (95% CI, 16.99–32.39). Surrounding La Poile, additional high incidence urban and rural FSAs (Figure 2A) such as St. John’s, Carbonea, Burin, Avalon, and Bonavista peninsulas were identified. Similarly, high incidence FSAs in Nova Scotia (Figure 2B) and Quebec (Figure 2C) favored remote rural communities. When looking at major urban centers, highest ASIRs were identified in Montreal (i.e., Montreal-Nord, Ahunstic-Cartierville, Villeray, Verdun, Lasalle, and Côte St-Luc boroughs) (Figure 2D) and Toronto (i.e., Scarborough, North York, and Etobicoke) (Figure 2E). Of note, most of these FSAs correspond to racially very diverse communities as, for example, in 2006 (Canadian Census data), 45.5% of people residing in Côte St-Luc and 50% of people in Scarborough self-identified as 1st-generation immigrants [35]. Importantly, among the 11 highest incidence FSAs, 4 (36%) were home to the First Nation communities. These included the Miawpukek (A0H), We’koqma’q (B0E), Gaspé (G0E), and Essipit (G0T) communities.

4. Discussion

In this manuscript, we present the epidemiology of gastric cancer based on CCR and LRQS databases for all available years (1992–2010) at provincial, municipal, and FSA postal code levels. To the best of our knowledge, no previous study has assessed the distribution of gastric cancer across the entire country to identify the correlation with SES/ethnicity and identify communities where a focused intervention may be important. At the national level, we confirm a decreasing burden of gastric cancer, a male predominance, an average age at diagnosis ~68 years, and a national ASIR of 5.07 cases per 100,000 individuals per year. Similar trends are observed in other developed countries, with decreasing incidence attributed to the decline of H. pylori infection, decreased rates of tobacco use, and changes in food preservation [36,37]. The overall ASIR in the US between 1999 and 2013, was reported as a range from 6.6 to 7.6 per 100,000 per year [38], age of diagnosis ~70 years of age [2], and male to female incidence ratio of 2.2:1 [3].
Our geographic mapping showed significantly higher ASIRs in Newfoundland and Labrador, mostly in rural areas and often affecting First Nation communities. Various modifiable risk factors are implicated in the pathogenesis of gastric adenocarcinoma such as obesity, and diets high in salt and processed foods [10,39,40,41]. Conversely, diets plentiful in vegetables and fruit have been shown to be protective [10]. In a report by Statistics Canada in 2008, the frequency of fruit and vegetable consumption was the lowest in Newfoundland and Labrador [42]. Additionally, in 2007, this province had one of the highest rates of food insecurity in Canada (15.7%), 4th only to remote regions such as Nunavut, and Yukon [43]. In 2008, Newfoundland and Labrador demonstrated the highest rate of obesity in the country, followed by the 3 other Maritime provinces [44]. This study additionally demonstrated that obese individuals were more likely to have a low consumption of fresh fruits and vegetables, live in rural areas, and have a low income [44]. In 2015, it was found that for every 100,000 Newfoundlanders, there were 14 fast food stores and only 3 grocery stores [45]. This is in contrast to a study published in 2010 which determined that the optimal quantity of grocery stores in a trade area would be 10 per 100,000 residents [46]. In 2014, it was estimated that the cities of Montreal and Vancouver had ~13 grocery stores per 100,000 residents, Edmonton and Calgary had ~10, and Toronto had ~9 [47].
Among the 11 highest incidence FSA found in our study, 4 (36%) were home to First Nation communities. These included the Miawpukek (A0H), We’koqma’q (B0E), Gaspé (G0E), and Essipit (G0T) communities [48,49,50] supporting recent literature showing 3-fold increase in gastric cancer incidence in Northern Canadian population [51]. In 2010, it was estimated that 28% of Inuit and 27% of First Nation community members experienced moderate to severe household food insecurity vs. 8% of average Canadians [52]. In 2012, it was estimated that 42% of Inuit in Nunatsiavut residing in Newfoundland and Labrador experienced food shortages [53]. Food insecurity is linked to the adoption of an unbalanced diet, decreased physical activity, and higher prevalence of obesity [54,55,56,57]. These issues may be further exacerbated by the disproportionately high cost of fresh food in northern Canadian communities [58]. In April 2011, the Nutrition North Canada (NNC) plan was put into action, resulting in savings of approximately 5% between 2011 and 2015, however, food insecurity in these remote regions continues to persist [58]. Therefore, for these reasons, indigenous populations, as corroborated by the findings of our study, may be at higher risk of developing gastric cancer.
Our findings of higher ASIR in Canadian immigrant population, particularly in areas with significantly higher Hispanic composition (1.47, 95% CI 1.35–1.60) is aligned with the previous literature demonstrating higher rates on gastric cancer among immigrants in Ontario [59]. The Statistics Canada report showed a rapid growth of Hispanic Canadian population, by 32% between 1996 and 2001 [60]. The vast majority of Hispanic individuals reside in large urban areas such as Toronto (31%), Montreal (23%), and Vancouver (9%) [60]. These cities also displayed a high incidence of gastric cancer in the present study. Hispanic, East Asian, and African-American/black individuals, as well as other immigrant groups from countries with high rates of gastric cancer, have been shown to possess at least a 2–3 times higher prevalence of gastric cancer as compared to Caucasians in the United States [11,12,61,62]. In a study conducted between 1999 and 2013, gastric cancer incidence was mapped throughout all 50 of the United States, demonstrating that the highest gastric cancer incidence rates were found in Texas and California, both states known to have a rapid growth of Hispanic populations. Many of the identified urban high incidence FSAs correspond to the most multicultural boroughs with the highest proportion of visible minorities. By example in 2006 (Canadian Census data), ~45–50% of people residing in Côte St-Luc and Scarborough self-identified as first-generation immigrants [35], these numbers remained identical in 2016 (44.8% in Côte St-Luc and 47% in Scarborough) [63].
SES is often established from a combination of multiple variables with the 3 most prominently used being education, income, and occupation [64]. The SES analysis by examination of income was performed in our study, demonstrating a significant association between gastric cancer incidence rates and postal code areas with a low mean income. While we were unable to examine the education and occupation status in the present study, all 3 individual risk factors have been previously associated with increased incidence of gastric cancer [64]. Geographic clustering of gastric cancer cases in the northern Romagna (Italy) region between 1987 and 2008 correlated with rural, low SES communities [65]. Low SES has been previously associated with increased incidence of gastric cancer, with two thirds of cases occurring in developing nations [66], hypothesized to be due to poor sanitation and increased risk of H. pylori infection, as well as decreased consumption of nutritional and fresh foods due to decreased income, education, and access to resources [67,68,69].
Given that annual income does not take into account how many people are supported by that income or if one is supported by someone else’s income, it may not be the most reliable indicator to use alone [70]. When examining gastric cancer incidence by occupation, several studies have demonstrated significantly increased risk of cancer among workers in transportation, woodworking, and manual workers in comparison with those in professional work settings [64,71,72]. When assessing instead education as the independent indicator, 2 large European-based studies demonstrated that patients with lower education levels had a higher incidence of gastric cancer, with the study by Nagel et al. having overall lower smoking rates, lower body mass index, and increased vegetable intake, strengthening this observation [73,74]. In fact, as per the study by Sarkar et al., among the 3 variables defining SES, the education level appears to be the most informative and reliable predictor of gastric cancer risk [64].
Our study limitations include first and foremost the retrospective design and data years available (1992–2010). Data for the Canadian territories were sparse and not statistically significant. Due to confidentiality regulations, the data could not be presented in its entirety due to the mandatory rounding of frequencies of cases to the nearest 5 or 10, as well as the suppression of data exhibiting frequencies that were lower than 5. For the same reason, localities with less than 5000 inhabitants had to be excluded. For smaller cities/FSAs due to a relatively low number of residents and/or low number of gastric cancer cases, ASIR could not be calculated, and crude incidence rates were used. Detailed spaciotemporal information is not available through cancer registries and, hence, FSAs at inception were used. Given that the databases used did not include data concerning patient ethnicity, SES, and other health related risk factors, indirect comparison was used.
The reported associations that were found when using area-based SES and ethnic composition analysis may not be applicable when examining individual-level factors such as SES and ethnicity, as these were indirectly correlated and could not be causally linked. Finally, given that the databases employed did not provide individual data concerning nutrition habits, income, and immigrant or First Nation composition of the populations with gastric cancer in each FSA, the interpretations discussed should be taken with caution in the context of ecological fallacy, as inferences about the nature and risk factors of gastric cancer cannot be made definitively based solely upon the aggregated data. More research is needed in order to define the geographical risk factors associated with gastric cancer with certainty.
This is the first study to describe the strikingly unequal geographic distribution of gastric cancer in Canada. Importantly, localities with highest ASIR of gastric cancer are characterized by statistically higher than national average rates of known risk factors, notably low SES, and non-Caucasian ethnicity (notably Hispanic and First-Nation). The highest incidence rates in our country corresponded to rural/remote communities where high rates of food insecurity, obesity, and/or other risk factors (e.g., visible minority, low SES) are well characterized. High incidence rates in First Nation communities were confirmed [51]. Identified high-risk communities should not be ignored as it is estimated that up to 30% of gastric cancer cases may be preventable through risk factor modification [75,76]. In Japan and South Korea, where nation-wide screening programs requiring all individuals >40 to undergo annual upper endoscopic exams have had a positive impact on the incidence and mortality of gastric cancer [77,78,79]. While it may not be feasible to adopt such a widespread screening guideline for all Canadians >40, it may be beneficial to consider earlier screening in high-risk communities who present with many of the aforementioned risk factors similar to the UK guidelines [76].

5. Conclusions

While the incidence rates of gastric cancer are decreasing in Canada, incidence rates vary greatly on the geographic location favoring rural areas in Newfoundland and Labrador, New Brunswick, and Quebec. First-nation and highly multicultural (particularly Hispanic) communities were identified among high incidence regions. The association with low SES was confirmed. A total of 11 FSAs had an ASIR of gastric cancer >3-fold that of the national average. Since ~30% of gastric cancer cases are thought to be preventable, targeting high risk communities is of particular interest to improve disease burden and survival.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/curroncol28030190/s1. Table S1: Incidence of gastric adenocarcinoma in Canadian cities. Cities are divided into high incidence (A) and low incidence (B) compared to the average gastric cancer incidence rate in Canada; Table S2: List of populous forward sortation areas (FSA) in Canada with high (A) and zero (B) incidence of gastric adenocarcinoma from 1992 to 2010; Table S3: List of populous forward sortation areas (FSA) in Canada with high incidence of gastric adenocarcinoma from 1992 to 2010, sorted by their association with either urban or rural areas of the country.

Author Contributions

L.C. collected and analyzed the data and wrote the article; F.M.G. analyzed the data and co-wrote the article; M.L. analyzed the data; F.L. performed statistical analyses; E.R. performed statistical analyses; A.Z. performed statistical analyses; D.S. collected the data, designed and supervised the study, and wrote the article; K.A.W. collected data, designed and supervised the study, and wrote the article; I.V.L. collected the data, designed and supervised the study, and wrote the article; E.N. supervised the study, analyzed the data, and co-wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Cole Foundation Grant to Litvinov, Canadian Foundation of Dermatology Foundation research grants to Sasseville and Litvinov and Fonds de recherche du Quebec—Santé (FRSQ #34753 and 36769) research grants to Litvinov. No funding bodies had any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Institutional Review Board Statement

The CISS-RDC-668035 and the 13-SSH-MCG-3749-S001 protocols were approved by the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Québec Inter-University Center for Social Statistics (QICSS), respectively. As per the institution policy, this study was exempted by the Research Ethics Board of McGill University.

Informed Consent Statement

Not applicable.

Data Availability Statement

3rd Party Data. Restrictions apply to the availability of these data. Data was obtained from the Canadian Cancer Registry (CCR) and Le Registre Québécois du Cancer (LRQC) and are available from the authors with the permission of Statistics Canada.

Conflicts of Interest

The authors declare no competing financial interests. The authors report no conflict of interest.

References

  1. Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics; Canadian Cancer Society: Toronto, ON, Canada, 2019. [Google Scholar]
  2. Karimi, P.; Islami, F.; Anandasabapathy, S.; Freedman, N.D.; Kamangar, F. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiol. Biomark. Prev. 2014, 23, 700–713. [Google Scholar] [CrossRef] [Green Version]
  3. Rawla, P.; Barsouk, A. Epidemiology of gastric cancer: Global trends, risk factors and prevention. Gastroenterol. Rev. 2019, 14, 26–38. [Google Scholar] [CrossRef]
  4. Kim, S.; Hwang, J. Assessment of trends in socioeconomic inequalities in cancer screening services in Korea, 1998–2012. Int. J. Equity Health 2016, 15, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Kim, G.H.; Liang, P.S.; Bang, S.J.; Hwang, J.H. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest. Endosc. 2016, 84, 18–28. [Google Scholar] [CrossRef] [Green Version]
  6. Ang, T.L.; Fock, K.M. Clinical epidemiology of gastric cancer. Singap. Med. J. 2014, 55, 621–628. [Google Scholar] [CrossRef] [Green Version]
  7. Casamayor, M.; Morlock, R.; Maeda, H.; Anjani, J. Targeted literature review of the global burden of gastric cancer. Ecancermedicalscience 2018, 12, 883. [Google Scholar] [CrossRef] [Green Version]
  8. Charalampakis, N.; Economopoulou, P.; Kotsantis, I.; Tolia, M.; Schizas, D.; Liakakos, T.; Elimova, E.; Ajani, J.A.; Psyrri, A. Medical management of gastric cancer: A 2017 update. Cancer Med. 2017, 7, 123–133. [Google Scholar] [CrossRef] [Green Version]
  9. Correa, P. Gastric cancer: Overview. Gastroenterol. Clin. N. Am. 2013, 42, 211–217. [Google Scholar] [CrossRef] [Green Version]
  10. Guggenheim, D.E.; Shah, M.A. Gastric cancer epidemiology and risk factors. J. Surg. Oncol. 2012, 107, 230–236. [Google Scholar] [CrossRef] [PubMed]
  11. Choi, C.E.; Sonnenberg, A.; Turner, K.; Genta, R.M. High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA. Dig. Dis. Sci. 2015, 60, 2070–2076. [Google Scholar] [CrossRef]
  12. Kim, Y.; Park, J.; Nam, B.-H.; Ki, M. Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011. Epidemiol. Health 2015, 37, e2015006. [Google Scholar] [CrossRef]
  13. Gupta, S.; Tao, L.; Murphy, J.D.; Camargo, M.C.; Oren, E.; Valasek, M.A.; Gomez, S.L.; Martinez, M.E. Race/Ethnicity-, Socioeconomic Status-, and Anatomic Subsite-Specific Risks for Gastric Cancer. Gastroenterology 2019, 156, 59–62.e4. [Google Scholar] [CrossRef]
  14. Petrelli, A.; Di Napoli, A.; Sebastiani, G.; Rossi, A.; Rossi, P.G.; Demuru, E.; Costa, G.; Zengarini, N.; Alicandro, G.; Marchetti, S.; et al. Italian Atlas of mortality inequalities by education level. Epidemiol. Prev. 2019, 43, 1–120. [Google Scholar] [PubMed]
  15. Lugn, N.E. Global health care–bridging the gap. J. Telemed. Telecare 2006, 12, 109–110. [Google Scholar] [CrossRef]
  16. The Lancet Global Health. Bridging the global health gap. Lancet Glob. Health 2016, 4, e579. [Google Scholar] [CrossRef] [Green Version]
  17. Tsang, M.; Le, M.; Ghazawi, F.M.; Cyr, J.; Alakel, A.; Rahme, E.; Lagacé, F.; Netchiporouk, E.; Moreau, L.; Zubarev, A.; et al. Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study. Cancer 2019, 125, 2435–2444. [Google Scholar] [CrossRef]
  18. Le, M.; Ghazawi, F.M.; Rahme, E.; Alakel, A.; Netchiporouk, E.; Savin, E.; Zubarev, A.; Glassman, S.J.; Sasseville, D.; Popradi, G.; et al. Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada. Cancer 2019, 125, 3953–3959. [Google Scholar] [CrossRef]
  19. Le, M.; Ghazawi, F.M.; Alakel, A.; Netchiporouk, E.; Rahme, E.; Zubarev, A.; Powell, M.; Moreau, L.; Roshdy, O.; Glassman, S.J.; et al. Incidence and Mortality Trends and Geographic Patterns of Follicular Lymphoma in Canada. Curr. Oncol. 2019, 26, 473–481. [Google Scholar] [CrossRef] [Green Version]
  20. Lagacé, F.; Ghazawi, F.M.; Le, M.; Savin, E.; Zubarev, A.; Powell, M.; Moreau, L.; Sasseville, D.; Popa, I.; Litvinov, I.V. Penile Invasive Squamous Cell Carcinoma: Analysis of Incidence, Mortality Trends, and Geographic Distribution in Canada. J. Cutan. Med. Surg. 2019, 24, 124–128. [Google Scholar] [CrossRef]
  21. Lagacé, F.; Ghazawi, F.M.; Le, M.; Rahme, E.; Savin, E.; Zubarev, A.; Alakel, A.; Sasseville, D.; Moreau, L.; Meterissian, S.; et al. Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada. Breast Cancer Res. Treat. 2019, 178, 683–691. [Google Scholar] [CrossRef]
  22. Ghazawi, F.M.; Ramanakumar, A.V.; Alakel, A.; Lagacé, F.; Chen, A.; Le, M.; Nedjar, H.; Sasseville, D.; Rahme, E.; Litvinov, I.V. Incidence of acute myeloid leukemia: A regional analysis of Canada. Cancer 2019, 126, 1356–1361. [Google Scholar] [CrossRef]
  23. Ghazawi, F.M.; Netchiporouk, E.; Rahme, E.; Tsang, M.; Moreau, L.; Glassman, S.; Provost, N.; Gilbert, M.; Jean, S.-E.; Roshdy, O.; et al. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010. J. Cutan. Med. Surg. 2017, 22, 154–165. [Google Scholar] [CrossRef]
  24. Ghazawi, F.M.; Netchiporouk, E.; Rahme, E.; Tsang, M.; Moreau, L.; Glassman, S.; Provost, N.; Gilbert, M.; Jean, S.-E.; Pehr, K.; et al. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Cancer 2017, 123, 3550–3567. [Google Scholar] [CrossRef] [Green Version]
  25. Ghazawi, F.M.; Lu, J.; Savin, E.; Zubarev, A.; Chauvin, P.; Sasseville, D.; Zeitouni, A.; Litvinov, I.V. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada. J. Cutan. Med. Surg. 2020, 24, 340–349. [Google Scholar] [CrossRef]
  26. Ghazawi, F.M.; Le, M.; Lagacé, F.; Cyr, J.; AlGhazawi, N.; Zubarev, A.; Roy, S.F.; Rahme, E.; Netchiporouk, E.; Roshdy, O.; et al. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada. J. Cutan. Med. Surg. 2019, 23, 394–412. [Google Scholar] [CrossRef]
  27. Ghazawi, F.M.; Le Bsc, M.; Cyr, J.; Netchiporouk, E.; Rahme, E.; Alakel, A.; Zubarev, A.; Powell, M.; Moreau, L.; Roshdy, O.; et al. Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario. Cancer 2019, 125, 1886–1897. [Google Scholar] [CrossRef]
  28. Ghazawi, F.M.; Le, M.; Alghazawi, N.; Rahme, E.; Moreau, L.; Netchiporouk, E.; Zubarev, A.; Roshdy, O.; Glassman, S.J.; Sasseville, D.; et al. Trends in incidence of cutaneous malignant melanoma in Canada: 1992–2010 versus 2011–2015. J. Am. Acad. Dermatol. 2019, 80, 1157–1159. [Google Scholar] [CrossRef] [Green Version]
  29. Ghazawi, F.M.; Darwich, R.; Le, M.; Rahme, E.; Zubarev, A.; Moreau, L.; Burnier, J.V.; Sasseville, D.; Burnier, M.N.; Litvinov, I.V. Uveal melanoma incidence trends in Canada: A national comprehensive population-based study. Br. J. Ophthalmol. 2019, 103, 1872–1876. [Google Scholar] [CrossRef]
  30. Ghazawi, F.M.; Cyr, J.; Darwich, R.; Le, M.; Rahme, E.; Moreau, L.; Netchiporouk, E.; Zubarev, A.; Roshdy, O.; Glassman, S.J.; et al. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study. J. Am. Acad. Dermatol. 2019, 80, 448–459. [Google Scholar] [CrossRef]
  31. Darwich, R.; Ghazawi, F.M.; Rahme, E.; Alghazawi, N.; Zubarev, A.; Moreau, L.; Sasseville, D.; Jr, M.N.B.; Litvinov, I.V. Epidemiology of ophthalmic lymphoma in Canada during 1992–2010. Br. J. Ophthalmol. 2019, 104, 1176–1180. [Google Scholar] [CrossRef]
  32. Cattelan, L.; Ghazawi, F.M.; Le, M.; Lagacé, F.; Savin, E.; Zubarev, A.; Gantchev, J.; Tomaszewski, M.; Sasseville, D.; Waschke, K.; et al. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study. Cancer Med. 2020, 9, 401–417. [Google Scholar] [CrossRef] [Green Version]
  33. Lagacé, F.; Ghazawi, F.; Le, M.; Savin, E.; Zubarev, A.; Powell, M.; Moreau, L.; Sasseville, D.; Popa, I.; Litvinov, I. Incidence and Mortality of Prostate Cancer in Canada during 1992–2010. Curr. Oncol. 2021, 28, 96. [Google Scholar] [CrossRef]
  34. Xiao, Y.; Cattelan, L.; Lagacé, F.; Ghazawi, F.M.; Alakel, A.; Grose, E.; Le, M.; Nechaev, V.; Sasseville, D.; Waschke, K.; et al. Epidemiologic trends and geographic distribution of patients with gallbladder and extrahepatic biliary tract cancers in Canada. HPB 2021. [Google Scholar] [CrossRef] [PubMed]
  35. 2006 Census of Population; Statistics Canada: Ottawa, ON, Canada, 2006.
  36. Venerito, M.; Vasapolli, R.; Rokkas, T.; Malfertheiner, P. Gastric cancer: Epidemiology, prevention, and therapy. Helicobacter 2018, 23 (Suppl. S1), e12518. [Google Scholar] [CrossRef] [Green Version]
  37. Pasechnikov, V.; Chukov, S.; Fedorov, E.; Kikuste, I.; Leja, M. Gastric cancer: Prevention, screening and early diagnosis. World J. Gastroenterol. 2014, 20, 13842–13862. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, Z.; Graham, D.Y.; Khan, A.; Balakrishnan, M.; Abrams, H.R.; El-Serag, H.B.; Thrift, A.P. Incidence of gastric cancer in the USA during 1999 to 2013: A 50-state analysis. Int. J. Epidemiol. 2018, 47, 966–975. [Google Scholar] [CrossRef]
  39. D’Elia, L.; Rossi, G.; Ippolito, R.; Cappuccio, F.P.; Strazzullo, P. Habitual salt intake and risk of gastric cancer: A meta-analysis of prospective studies. Clin. Nutr. 2012, 31, 489–498. [Google Scholar] [CrossRef]
  40. Tramacere, I.; Negri, E.; Pelucchi, C.; Bagnardi, V.; Rota, M.; Scotti, L.; Islami, F.; Corrao, G.; La Vecchia, C.; Boffetta, P. A meta-analysis on alcohol drinking and gastric cancer risk. Ann. Oncol. 2012, 23, 28–36. [Google Scholar] [CrossRef] [PubMed]
  41. Chen, Y.; Liu, L.; Wang, X.; Wang, J.; Yan, Z.; Cheng, J.; Gong, G.; Li, G. Body Mass Index and Risk of Gastric Cancer: A Meta-analysis of a Population with More Than Ten Million from 24 Prospective Studies. Cancer Epidemiol. Biomark. Prev. 2013, 22, 1395–1408. [Google Scholar] [CrossRef] [Green Version]
  42. Canada, S. Fruit and Vegetable Consumption; Statistics Canada: Ottawa, ON, Canada, 2008.
  43. Tarasuk, V.; Mitchell, A.; Dachner, N. Research to identify policy options to reduce food insecurity. Household Food Insecurity in Canada 2011; Toronto, ON, Canada, 2013. Available online: https://proof.utoronto.ca/ (accessed on 1 May 2021).
  44. Canada PHAo. Obesity in Canada: A Joint Report from the Public Health Agency of Canada. And the Canadian Institute for Health Information; Canadian Institute for Health Information: Ottawa, ON, Canada, 2011. [Google Scholar]
  45. Food First NL Summary and Discussion Guide; Newfoundland and Labrador Public Health Association: St. John’s, NL, Canada, 2015.
  46. NYC Full Service Grocery Store Analysis; NYC Department of Health and Mental Hygiene: New York, NY, USA, 2010.
  47. Grocery Stores in Canadian Urban Centres; University of Alberta School of Retailing: Edmonton, AB, Canada, 2015.
  48. Quebec First Nations. 500 Nations; QC, Canada, 2020. Available online: https://www.500nations.com/Quebec_Tribes.asp (accessed on 1 May 2021).
  49. We’koqma’q First Nation; Nova Scotia Office of Aboriginal Affairs: Halifax, NS, Canada, 2020.
  50. Michelin, O. Reserves in Newfoundland and Labrador. In The Canadian Encyclopedia; Historica Canada: Toronto, ON, Canada, 2019; Available online: https://www.thecanadianencyclopedia.ca/en/article/reserves-in-newfoundland-and-labrador (accessed on 1 May 2021).
  51. Colquhoun, A.; Hannah, H.; Corriveau, A.; Hanley, B.; Yuan, Y.; Goodman, K.J.; The CANHelp Working Group. Gastric Cancer in Northern Canadian Populations: A Focus on Cardia and Non-Cardia Subsites. Cancers 2019, 11, 534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Aboriginal Food Security in Northern Canada: An Assessment of the State of Knowledge; Council of Canadian Academics: Ottawa, ON, Canada, 2014.
  53. Food Insecurity among Inuit living in Inuit Nunangat; Statistics Canada: Ottawa, ON, Canada, 2017.
  54. Egeland, G.M.; Johnson-Down, L.; Cao, Z.R.; Sheikh, N.; Weiler, H. Food Insecurity and Nutrition Transition Combine to Affect Nutrient Intakes in Canadian Arctic Communities. J. Nutr. 2011, 141, 1746–1753. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Kirkpatrick, S.I.; Tarasuk, V. Food Insecurity Is Associated with Nutrient Inadequacies among Canadian Adults and Adolescents. J. Nutr. 2008, 138, 604–612. [Google Scholar] [CrossRef] [PubMed]
  56. To, Q.G.; Frongillo, E.A.; Gallegos, D.; Moore, J.B. Household food insecurity is associated with less physical activity among children and adults in the U.S. population. J. Nutr. 2014, 144, 1797–1802. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Bhawra, J.; Cooke, M.J.; Guo, Y.; Wilk, P. The association of household food security, household characteristics and school environment with obesity status among off-reserve First Nations and Metis children and youth in Canada: Results from the 2012 Aboriginal Peoples Survey. Health Promot. Chronic Dis. Prev. Can. 2017, 37, 77–86. [Google Scholar] [CrossRef] [Green Version]
  58. Nutrition North Canada: Results from 2011–2016; Government of Canada: Ottawa, ON, Canada, 2016.
  59. Paszat, L.; Sutradhar, R.; Liu, Y.; Baxter, N.N.; Tinmouth, J.; Rabeneck, L. Risk of colorectal cancer among immigrants to Ontario, Canada. BMC Gastroenterol. 2017, 17, 85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Lindsay, C. The Latin American Community in Canada; Social and Aboriginal Statistics Division; Statistics Canada: Ottawa, ON, Canada, 2001.
  61. Chang, E.T.; Gomez, S.L.; Fish, K.; Schupp, C.W.; Parsonnet, J.; DeRouen, M.C.; Keegan, T.H.M.; Clarke, C.A.; Glaser, S.L. Gastric Cancer Incidence among Hispanics in California: Patterns by Time, Nativity, and Neighborhood Characteristics. Cancer Epidemiol. Biomark. Prev. 2012, 21, 709–719. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Wu, X.; Chen, V.W.; Ruiz, B.; Andrews, P.; Su, L.J.; Correa, P. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: Subsite and histology differences. Cancer 2006, 106, 683–692. [Google Scholar] [CrossRef]
  63. 2016 Census of Population; Statistics Canada: Ottawa, ON, Canada, 2016.
  64. Sarkar, S.; Dauer, M.J.; In, H. Socioeconomic Disparities in Gastric Cancer and Identification of a Single SES Variable for Predicting Risk. J. Gastrointest. Cancer 2021, 1–9. [Google Scholar] [CrossRef]
  65. Mancini, S.; Ravaioli, A.; Giuliani, O.; Giorgetti, S.; Falcini, F.; Colamartini, A.; Bucchi, L. Gastric cancer incidence in the Romagna Region of Italy: A spatial and temporal analysis. Dig. Liver Dis. 2015, 47, 1076–1081. [Google Scholar] [CrossRef]
  66. Crew, K.D.; Neugut, A.I. Epidemiology of gastric cancer. World J. Gastroenterol. 2006, 12, 354–362. [Google Scholar] [CrossRef]
  67. Webb, P.M.; Knight, T.; Greaves, S.; Wilson, A.; Newell, D.G.; Elder, J.; Forman, D. Relation between infection with Helicobacter pylori and living conditions in childhood: Evidence for person to person transmission in early life. BMJ 1994, 308, 750–753. [Google Scholar] [CrossRef] [Green Version]
  68. Buckley, M.J.M.; O’shea, J.; Grace, A.; English, L.; Keane, C.; Hourihan, D.; O’morain, C.A. A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology. Eur. J. Gastroenterol. Hepatol. 1998, 10, 375–380. [Google Scholar] [CrossRef]
  69. Kurosawa, M.; Kikuchi, S.; Inaba, Y.; Ishibashi, T.; Kobayashi, F. Helicobacter pylori infection among Japanese children. J. Gastroenterol. Hepatol. 2000, 15, 1382–1385. [Google Scholar] [CrossRef]
  70. Krieger, N.; Williams, D.R.; Moss, N.E. Measuring Social Class in US Public Health Research: Concepts, Methodologies, and Guidelines. Annu. Rev. Public Health 1997, 18, 341–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Engel, L.S.; Vaughan, T.L.; Gammon, M.D.; Chow, W.-H.; Risch, H.A.; Dubrow, R.; Mayne, S.T.; Rotterdam, H.; Schoenberg, J.B.; Stanford, J.L.; et al. Occupation and risk of esophageal and gastric cardia adenocarcinoma. Am. J. Ind. Med. 2002, 42, 11–22. [Google Scholar] [CrossRef] [PubMed]
  72. Hemminki, K.; Zhang, H.; Czene, K. Socioeconomic factors in cancer in Sweden. Int. J. Cancer 2003, 105, 692–700. [Google Scholar] [CrossRef] [PubMed]
  73. Lagergren, J.; Andersson, G.; Talbäck, M.; Drefahl, S.; Bihagen, E.; Härkönen, J.; Feychting, M.; Ljung, R. Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site. Cancer 2015, 122, 207–212. [Google Scholar] [CrossRef]
  74. Nagel, G.; Linseisen, J.; Boshuizen, H.C.; Pera, G.; Del Giudice, G.; Westert, G.P.; Bueno-De-Mesquita, H.B.; Allen, N.E.; Key, T.J.; Numans, M.E.; et al. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int. J. Epidemiol. 2007, 36, 66–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Zali, H.; Rezaei-Tavirani, M.; Azodi, M.Z. Gastric cancer: Prevention, risk factors and treatment. Gastroenterol. Hepatol. Bed Bench 2011, 4, 175–185. [Google Scholar] [PubMed]
  76. Banks, M.; Graham, D.; Jansen, M.; Gotoda, T.; Coda, S.; Di Pietro, M.; Uedo, N.; Bhandari, P.; Pritchard, D.M.; Kuipers, E.J.; et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019, 68, 1545–1575. [Google Scholar] [CrossRef] [Green Version]
  77. Ohata, H.; Oka, M.; Yanaoka, K.; Shimizu, Y.; Mukoubayashi, C.; Mugitani, K.; Iwane, M.; Nakamura, H.; Tamai, H.; Arii, K.; et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci. 2005, 96, 713–720. [Google Scholar] [CrossRef] [PubMed]
  78. Jun, J.K.; Choi, K.S.; Lee, H.-Y.; Suh, M.; Park, B.; Song, S.H.; Jung, K.W.; Lee, C.W.; Choi, I.J.; Park, E.-C.; et al. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology 2017, 152, 1319–1328.e7. [Google Scholar] [CrossRef] [PubMed]
  79. Choi, K.S.; Jun, J.K.; Lee, H.-Y.; Park, S.; Jung, K.W.; Han, M.A.; Choi, I.J.; Park, E.-C. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Sci. 2011, 102, 1559–1564. [Google Scholar] [CrossRef] [PubMed]
Curroncol 28 00190 g001 550
Figure 1. Incidence of gastric cancer throughout Canada between 1992 and 2010 over time and by province (in cases per 100,000 individuals per year) (A) Changing incidence rates for gastric between 1992 and 2010. (B) Incidence rates of gastric cancer in the Canadian provinces between 1992 to 2010.
Figure 1. Incidence of gastric cancer throughout Canada between 1992 and 2010 over time and by province (in cases per 100,000 individuals per year) (A) Changing incidence rates for gastric between 1992 and 2010. (B) Incidence rates of gastric cancer in the Canadian provinces between 1992 to 2010.
Curroncol 28 00190 g001
Curroncol 28 00190 g002 550
Figure 2. Gastric cancer high incidence FSA in the Maritimes, Quebec, Ontario, and Western Canada. Geographic maps illustrate incidence rates of gastric adenocarcinoma (cases per 100,000 individuals per year) relative to the national average based on the Canadian Cancer Registry/Quebec Cancer Registry databases. (A) Newfoundland and Labrador: Highest incidence FSA A0M, representing the La Poile Bay region, as well as Southwestern, Central and Northeastern rural areas of Newfoundland, Carbonea, St John’s, and finally the Avalon and Bonavista peninsula. (B) Nova Scotia in West Cape Breton, North Sydney, Glace Bay, Canso and Cobequid Bay. (C) High incidence FSAs in Eastern Quebec and New Brunswick involving Manicouagn, Le Fjord, Baie-Comeau, Rimouski, Mont-Joli, Gaspésie in Quebec, and Atholville, Bathurst, Tracadie-Sheila and Miramichi. (D) Montreal: Montreal-Nord, Ahunstic-Cartierville, and Villeray, Verdun, Lasalle, Côte St-Luc. (E) Greater Toronto Area: Scarborough, North York, and Etobicoke. (F) British Columbia: Vancouver. (G) Alberta: Edmonton. (H) Manitoba: Winnipeg.
Figure 2. Gastric cancer high incidence FSA in the Maritimes, Quebec, Ontario, and Western Canada. Geographic maps illustrate incidence rates of gastric adenocarcinoma (cases per 100,000 individuals per year) relative to the national average based on the Canadian Cancer Registry/Quebec Cancer Registry databases. (A) Newfoundland and Labrador: Highest incidence FSA A0M, representing the La Poile Bay region, as well as Southwestern, Central and Northeastern rural areas of Newfoundland, Carbonea, St John’s, and finally the Avalon and Bonavista peninsula. (B) Nova Scotia in West Cape Breton, North Sydney, Glace Bay, Canso and Cobequid Bay. (C) High incidence FSAs in Eastern Quebec and New Brunswick involving Manicouagn, Le Fjord, Baie-Comeau, Rimouski, Mont-Joli, Gaspésie in Quebec, and Atholville, Bathurst, Tracadie-Sheila and Miramichi. (D) Montreal: Montreal-Nord, Ahunstic-Cartierville, and Villeray, Verdun, Lasalle, Côte St-Luc. (E) Greater Toronto Area: Scarborough, North York, and Etobicoke. (F) British Columbia: Vancouver. (G) Alberta: Edmonton. (H) Manitoba: Winnipeg.
Curroncol 28 00190 g002
Table
Table 1. Prevalence of different subtypes of gastric adenocarcinoma analyzed in Canada between 1992 and 2010.
Table 1. Prevalence of different subtypes of gastric adenocarcinoma analyzed in Canada between 1992 and 2010.
Gastric Adenocarcinoma SubtypesICD-O-3 CodeNo. of PatientsPercentage of Total
Adenocarcinoma814029,13566.3
Intestinal adenocarcinoma8144452510.3
Diffuse adenocarcinoma814515353.6
Tubular adenocarcinoma82114301.0
Papillary adenocarcinoma82602200.5
Mucinous adenocarcinoma84808251.9
Signet ring cell carcinoma8490695515.8
Medullary carcinoma851250.01
Adenosquamous carcinoma85601650.3
Undifferentiated carcinoma80201600.3
Overall Gastric Adenocarcinoma-43,955100
Table
Table 2. Epidemiologic characteristics of gastric adenocarcinoma in Canada between 1992 and 2010.
Table 2. Epidemiologic characteristics of gastric adenocarcinoma in Canada between 1992 and 2010.
Patient DemographicsIncidence
Total number of patients 43,955
By sex
Number of males (%)28,830 (66%)
Number of females (%)15,125 (34%)
By age group
<100 (0%)
10–195 (0.01%)
20–29175 (4.0%)
30–39990 (2.3%)
40–493155 (7.2%)
50–596490 (15%)
60–6911,005 (25%)
70–7913,800 (31%)
80–897490 (17%)
90+825 (1.9%)
Average age 68.36 ± 0.51
Average ASIR in Males
in number of cases per 100,000 individuals per year (95% CI)		6.74 (6.64–6.83)
Average ASIR in Females
in number of cases per 100,000 individuals per year (95% CI)		3.41 (3.34–3.47)
Table
Table 3. Quintile analysis of gastric adenocarcinoma incidence by socioeconomic status and ethnicity. Incidence rate ratios represent the ratio between the incidence rate of the given quintile and Q1.
Table 3. Quintile analysis of gastric adenocarcinoma incidence by socioeconomic status and ethnicity. Incidence rate ratios represent the ratio between the incidence rate of the given quintile and Q1.
A: Socioeconomic Status
QuintileMedian Income ($)Incidence Rate (per 100,000)Incidence Rate Ratio (95% CI)
Q1<20,0009.17-
Q220,000–25,0007.350.80 (0.78–0.82)
Q325,000–30,0005.860.64 (0.62–0.66)
Q430,000–35,0004.430.48 (0.46–0.51)
Q5>35,0003.530.39 (0.35–0.42)
B: Ethnicity
QuintilePercentage of Hispanic Individuals
(%)		Incidence Rate
(per 100,000)		Incidence Rate Ratio (95% CI)
Q10.007.69-
Q20.01–1.997.170.93 (0.89–0.98)
Q32.00–3.997.520.98 (0.92–1.03)
Q44.00–5.999.611.25 (1.15–1.35)
Q5>6.0011.321.47 (1.35–1.60)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cattelan, L.; Ghazawi, F.M.; Le, M.; Lagacé, F.; Rahme, E.; Zubarev, A.; Sasseville, D.; Litvinov, I.V.; Waschke, K.A.; Netchiporouk, E. Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada. Curr. Oncol. 2021, 28, 2052-2064. https://doi.org/10.3390/curroncol28030190

AMA Style

Cattelan L, Ghazawi FM, Le M, Lagacé F, Rahme E, Zubarev A, Sasseville D, Litvinov IV, Waschke KA, Netchiporouk E. Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada. Current Oncology. 2021; 28(3):2052-2064. https://doi.org/10.3390/curroncol28030190

Chicago/Turabian Style

Cattelan, Leila, Feras M. Ghazawi, Michelle Le, François Lagacé, Elham Rahme, Andrei Zubarev, Denis Sasseville, Ivan V. Litvinov, Kevin A. Waschke, and Elena Netchiporouk. 2021. "Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada" Current Oncology 28, no. 3: 2052-2064. https://doi.org/10.3390/curroncol28030190

APA Style

Cattelan, L., Ghazawi, F. M., Le, M., Lagacé, F., Rahme, E., Zubarev, A., Sasseville, D., Litvinov, I. V., Waschke, K. A., & Netchiporouk, E. (2021). Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada. Current Oncology, 28(3), 2052-2064. https://doi.org/10.3390/curroncol28030190

Article Metrics

Back to TopTop